Health Condition 1: L639- Alopecia areata, unspecified
Conditions
Interventions
Intervention1: Oral Betamethasone minipulse therapy: Betamethasone oral mini-pulse 0.1mg/kg body wt./dose on two consecutive days per week for 12 weeks
Control Intervention1: Oral Cyclosporine: Oral
Sponsors
Shibashis Chatterjee
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients consenting for the study. 2.All the patients presenting with circumscribed patch of hair loss without any signs of inflammation or scarring,of size > 3cm in diameter. 3.Patients who have symptoms of 3 months or more duration. 4.Patients who have not taken any other modalities of treatment in the last 3 months.
Exclusion criteria
Exclusion criteria: 1.Patients who are k/c/o hypertension. 2.Patients with secondary infection. 3.Pregnant and lactating females. 4.Patients with pre-existing renal and liver diseases. 5.Patients with diabetes mellitus. 6.Patients having any Autoimmune disease like SLE, Sjogrenâ??s Syndrome,etc. 7.Patients having contraindications to the drugs used in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety of the drugsTimepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Therapeutic efficacy of the drugsTimepoint: 3 months | — |
Countries
India
Contacts
Public ContactShibashis Chatterjee
KIMS & PBM Hospital Bhubaneswar
Outcome results
None listed